136 related articles for article (PubMed ID: 24344007)
1. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.
Can A; Alacacioglu A; Kucukzeybek Y; Erten C; Cokmert S; Demir L; Dirican A; Vedat Bayoglu I; Akyol M; Aslan F; Oktay Tarhan M
J BUON; 2013; 18(4):845-50. PubMed ID: 24344007
[TBL] [Abstract][Full Text] [Related]
2. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
3. Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients.
Abu Rabi Z; Todorovic-Rakovic N; Markicevic M; Stamatovic L; Vujasinovic T; Nikolic-Vukosavljevic D
J BUON; 2013; 18(2):321-7. PubMed ID: 23818341
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
Healy LA; Ryan AM; Carroll P; Ennis D; Crowley V; Boyle T; Kennedy MJ; Connolly E; Reynolds JV
Clin Oncol (R Coll Radiol); 2010 May; 22(4):281-8. PubMed ID: 20189371
[TBL] [Abstract][Full Text] [Related]
5. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
6. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women.
Lee SW; Jo HH; Kim MR; You YO; Kim JH
Gynecol Endocrinol; 2012 Jun; 28(6):472-7. PubMed ID: 22114890
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria.
Kocełak P; Chudek J; Olszanecka-Glinianowicz M
Minerva Endocrinol; 2012 Sep; 37(3):247-54. PubMed ID: 22766891
[TBL] [Abstract][Full Text] [Related]
8. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
9. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
11. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance.
Esteghamati A; Ashraf H; Esteghamati AR; Meysamie A; Khalilzadeh O; Nakhjavani M; Abbasi M
Diabetes Res Clin Pract; 2009 Jun; 84(3):279-87. PubMed ID: 19359063
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
15. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
16. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome.
Santamaria A; Giordano D; Corrado F; Pintaudi B; Interdonato ML; Vieste GD; Benedetto AD; D'Anna R
Climacteric; 2012 Oct; 15(5):490-5. PubMed ID: 22192068
[TBL] [Abstract][Full Text] [Related]
17. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.
Goodwin PJ; Ennis M; Bahl M; Fantus IG; Pritchard KI; Trudeau ME; Koo J; Hood N
Breast Cancer Res Treat; 2009 Apr; 114(3):517-25. PubMed ID: 18437560
[TBL] [Abstract][Full Text] [Related]
18. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
Todorovic-Rakovic N; Neskovic-Konstantinovic Z
J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
[TBL] [Abstract][Full Text] [Related]
19. Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women.
Karelis AD; Henry JF; St-Pierre DH; Prud'homme D; Rabasa-Lhoret R
Diabetes Obes Metab; 2006 May; 8(3):336-41. PubMed ID: 16634994
[TBL] [Abstract][Full Text] [Related]
20. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
